180 related articles for article (PubMed ID: 38007383)
61. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M
J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863
[TBL] [Abstract][Full Text] [Related]
62. [Clinical and genetic characterization of FIPA (familial isolated pituitary adenomas)].
Beckers A; Apetrii P; Daly A; Tichomirova M; Vanbellingen JF; Georges M; Bours V
Rev Med Liege; 2009; 64 Spec No():15-9. PubMed ID: 20085010
[TBL] [Abstract][Full Text] [Related]
63. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
[TBL] [Abstract][Full Text] [Related]
64. [Familial pituitary adenomas: clinical and genetic aspects].
Bricaire L; Brue T
Ann Endocrinol (Paris); 2007 Jun; 68 Suppl 1():9-11. PubMed ID: 17961654
[TBL] [Abstract][Full Text] [Related]
65. Risk category system to identify pituitary adenoma patients with
Caimari F; Hernández-Ramírez LC; Dang MN; Gabrovska P; Iacovazzo D; Stals K; Ellard S; Korbonits M;
J Med Genet; 2018 Apr; 55(4):254-260. PubMed ID: 29440248
[TBL] [Abstract][Full Text] [Related]
66. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
[TBL] [Abstract][Full Text] [Related]
67. AIP gene and familial isolated pituitary adenomas.
Ozfirat Z; Korbonits M
Mol Cell Endocrinol; 2010 Sep; 326(1-2):71-9. PubMed ID: 20457215
[TBL] [Abstract][Full Text] [Related]
68. [Familial pituitary adenomas].
Burlacu MC; Tichomirowa M; Daly A; Beckers A
Presse Med; 2009 Jan; 38(1):112-6. PubMed ID: 18990538
[TBL] [Abstract][Full Text] [Related]
69. Familial isolated pituitary adenomas experience at a single center: clinical importance of AIP mutation screening.
Pinho LK; Vieira Neto L; Wildemberg LE; Moraes AB; Takiya CM; Frohman LA; Korbonits M; Gadelha MR
Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):698-704. PubMed ID: 21340155
[TBL] [Abstract][Full Text] [Related]
70. Familial pituitary tumor syndromes.
Vasilev V; Daly AF; Petrossians P; Zacharieva S; Beckers A
Endocr Pract; 2011; 17 Suppl 3():41-6. PubMed ID: 21613050
[TBL] [Abstract][Full Text] [Related]
71. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.
Georgitsi M; Raitila A; Karhu A; Tuppurainen K; Mäkinen MJ; Vierimaa O; Paschke R; Saeger W; van der Luijt RB; Sane T; Robledo M; De Menis E; Weil RJ; Wasik A; Zielinski G; Lucewicz O; Lubinski J; Launonen V; Vahteristo P; Aaltonen LA
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4101-5. PubMed ID: 17360484
[TBL] [Abstract][Full Text] [Related]
72. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
[TBL] [Abstract][Full Text] [Related]
73. [Genetic screening for mutations enables early diagnosis of pituitary adenomas].
Dal J; Gaustadnes M; Kristensen K; Gravholt CH; Jørgensen JO
Ugeskr Laeger; 2014 Jan; 176(1):54-7. PubMed ID: 24629609
[TBL] [Abstract][Full Text] [Related]
74. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].
Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A
Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897
[TBL] [Abstract][Full Text] [Related]
75. Update on the treatment of pituitary adenomas: familial and genetic considerations.
Daly AF; Beckers A
Acta Clin Belg; 2008; 63(6):418-24. PubMed ID: 19170361
[TBL] [Abstract][Full Text] [Related]
76. Pituitary tumours: molecular and genetic aspects.
De Sousa SMC; Lenders NF; Lamb LS; Inder WJ; McCormack A
J Endocrinol; 2023 Jun; 257(3):. PubMed ID: 36951812
[TBL] [Abstract][Full Text] [Related]
77. Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications.
Jaffrain-Rea ML; Daly AF; Angelini M; Petrossians P; Bours V; Beckers A
Expert Rev Endocrinol Metab; 2011 Mar; 6(2):195-214. PubMed ID: 30290451
[TBL] [Abstract][Full Text] [Related]
78. Bilateral pituitary adenomas occurring with multiple endocrine neoplasia type one.
Sahdev A; Jäger R
AJNR Am J Neuroradiol; 2000; 21(6):1067-9. PubMed ID: 10871015
[TBL] [Abstract][Full Text] [Related]
79. [Genetics of familial pituitary adenomas].
Beckers A; Jaffrain-Rea ML; Daly AE
Bull Acad Natl Med; 2009 Oct; 193(7):1557-70; discussion 1570-1. PubMed ID: 20669636
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]